Revision as of 08:14, 20 October 2011 editBeetstra (talk | contribs)Edit filter managers, Administrators172,031 edits Script assisted update of identifiers for the Chem/Drugbox validation project (updated: 'ChEMBL', 'CASNo').← Previous edit |
Latest revision as of 06:57, 5 January 2024 edit undoMaxim Masiutin (talk | contribs)Extended confirmed users, IP block exemptions, Pending changes reviewers30,619 edits Add: s2cid. |
(37 intermediate revisions by 27 users not shown) |
Line 1: |
Line 1: |
|
{{chembox |
|
{{chembox |
|
|
|Verifiedfields = changed |
⚫ |
| verifiedrevid = 399892399 |
|
|
|
|Watchedfields = changed |
⚫ |
|ImageFile=Desmethoxyyangonin.svg |
|
|
⚫ |
|verifiedrevid = 456483554 |
⚫ |
|IUPACName=4-methoxy-6--2''H''-pyran-2-one |
|
|
⚫ |
|ImageFile1=Desmethoxyyangonin.svg |
⚫ |
|OtherNames=5,6-Dehydrokawain<br/>4-methoxy-6--2-pyranone |
|
|
|
|ImageFile2=Desmethoxyyangonin02.png |
|
⚫ |
|PIN = 4-Methoxy-6--2''H''-pyran-2-one |
|
⚫ |
|OtherNames = (''E'')-4-Methoxy-6-styryl-2''H''-pyran-2-one<br />5,6-Dehydrokavain<br />4-Methoxy-6--2-pyranone |
|
|Section1={{Chembox Identifiers |
|
|Section1={{Chembox Identifiers |
|
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
|ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}} |
|
| ChemSpiderID = 4438012 |
|
|ChemSpiderID = 4438012 |
|
| InChI = 1/C14H12O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-10H,1H3/b8-7+ |
|
|InChI = 1/C14H12O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-10H,1H3/b8-7+ |
|
| InChIKey = DKKJNZYHGRUXBS-BQYQJAHWBF |
|
|InChIKey = DKKJNZYHGRUXBS-BQYQJAHWBF |
|
| SMILES1 = O=C/1O\C(=CC(\OC)=C\1)\C=C\c2ccccc2 |
|
|SMILES1 = O=C/1O\C(=CC(\OC)=C\1)\C=C\c2ccccc2 |
|
| StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
|StdInChI_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChI = 1S/C14H12O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-10H,1H3/b8-7+ |
|
|StdInChI = 1S/C14H12O3/c1-16-13-9-12(17-14(15)10-13)8-7-11-5-3-2-4-6-11/h2-10H,1H3/b8-7+ |
|
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
|StdInChIKey_Ref = {{stdinchicite|correct|chemspider}} |
|
| StdInChIKey = DKKJNZYHGRUXBS-BQYQJAHWSA-N |
|
|StdInChIKey = DKKJNZYHGRUXBS-BQYQJAHWSA-N |
|
|
|CASNo_Ref = {{cascite|correct|CAS}} |
|
| CASNo = <!-- blanked - oldvalue: 1952-41-6 --> |
|
|
|
|CASNo=15345-89-8 |
⚫ |
| ChEMBL = 254218 |
|
|
|
|UNII_Ref = {{fdacite|correct|FDA}} |
⚫ |
| PubChem=5273621 |
|
|
|
|UNII = F2MBQ8QRUN |
⚫ |
| SMILES=COC1=CC(=O)OC(=C1)C=CC2=CC=CC=C2 |
|
|
|
|ChEMBL_Ref = {{ebicite|correct|EBI}} |
⚫ |
}} |
|
|
⚫ |
|ChEMBL = 254218 |
|
⚫ |
|PubChem=5273621 |
|
⚫ |
|SMILES=COC1=CC(=O)OC(=C1)C=CC2=CC=CC=C2 |
|
⚫ |
}} |
|
|Section2={{Chembox Properties |
|
|Section2={{Chembox Properties |
|
| C=14 |H=12 |O=3 |
|
|C=14 | H=12 | O=3 |
|
| Appearance= |
|
|Appearance= white to faint yellow powder |
|
| Density= |
|
|Density= 1.18 g/mL |
|
|
|MeltingPtC= 148 |
|
| MeltingPt= |
|
|
|
|BoilingPtC= 440 |
|
| BoilingPt= |
|
|
⚫ |
}} |
|
| Solubility= |
|
⚫ |
}} |
|
|
|Section3={{Chembox Hazards |
|
|
| MainHazards= |
|
|
| FlashPt= |
|
|
| Autoignition= |
|
|
}} |
|
|
}} |
|
}} |
|
|
|
|
'''Desmethoxyyangonin''' or '''5,6-dehydrokawain''' is one of the six major ]s found in the '']'' (kava) plant. |
|
'''Desmethoxyyangonin''' or '''5,6-dehydrokavain''' is one of the six main ]s found in the '']'' (kava) plant. |
|
|
|
|
|
==Pharmacology== |
|
==Pharmacology== |
|
|
Desmethoxyyangonin is a reversible ] of ] (MAO-B).<ref>{{cite journal|last=Uebelhack|first=R|author2=Franke L |author3=Schewe HL |title=Inhibition of platelet MAO-B by kava pyrone-enriched extract from Piper methysticum Forster (kava-kava)|journal=Pharmacopsychiatry|date=September 1998|volume=31|issue=5|pages=187–192|doi=10.1055/s-2007-979325|pmid=9832350|s2cid=25270815}}</ref> Kava is able to increase ] levels in the ]<ref>{{cite journal|last=Baum|first=SS|author2=Hill R |author3=Rommelspacher H |title=Effect of kava extract and individual kavapyrones on neurotransmitter levels in the nucleus accumbens of rats|journal=Progress in Neuro-Psychopharmacology and Biological Psychiatry|date=October 1998|volume=22|issue=7|pages=1105–1120|doi=10.1016/S0278-5846(98)00062-1|pmid=9829291|s2cid=24377397}}</ref> and desmethoxyyangonin likely contributes to this effect. This, along with several other catecholamines, may be responsible for the purported attention-promoting effects of kava. |
|
|
|
|
|
|
Unlike the other major kavalactones, desmethoxyyangonin does not appear to act as a ].<ref>{{cite journal | url=https://pubmed.ncbi.nlm.nih.gov/9776662/ | pmid=9776662 | year=1998 | last1=Boonen | first1=G. | last2=Häberlein | first2=H. | title=Influence of genuine kavapyrone enantiomers on the GABA-A binding site | journal=Planta Medica | volume=64 | issue=6 | pages=504–506 | doi=10.1055/s-2006-957502 | s2cid=45511040 }}</ref> |
|
Desmethoxyyangonin is a reversible ] of ] (MAO-B). It is able to increase ] levels in the ]. This may be the reason for the ] from Kava consumption. |
|
|
|
|
|
|
Desmethoxyyangonin has marked activity on the induction of ].<ref name='Ma 2004'> {{cite journal|title=Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23.|journal=Drug Metabolism and Disposition|date=2004 November|first=Yuzhong|last=Ma|coauthors=Karuna Sachdeva, Jirong Liu1, Michael Ford, Dongfang Yang, Ikhlas Khan, Clinton Chichester, Bingfang Yan|volume=32|issue=11|pages=1317–1324|pmid=15282211|doi=10.1124/dmd.104.000786}}</ref> |
|
Desmethoxyyangonin has marked activity on the induction of ].<ref name='Ma 2004'>{{cite journal|title=Desmethoxyyangonin and dihydromethysticin are two major pharmacological kavalactones with marked activity on the induction of CYP3A23|journal=Drug Metabolism and Disposition|date=November 2004|first=Yuzhong|last=Ma|author2=Karuna Sachdeva |author3=Jirong Liu1 |author4=Michael Ford |author5=Dongfang Yang |author6=Ikhlas Khan |author7=Clinton Chichester |author8=Bingfang Yan |volume=32|issue=11|pages=1317–1324|pmid=15282211|doi=10.1124/dmd.104.000786|s2cid=43840844}}</ref> |
|
|
|
|
|
⚫ |
==See also== |
|
⚫ |
*] |
|
==References== |
|
==References== |
|
{{reflist}} |
|
{{Reflist|2}} |
|
|
|
⚫ |
==See also== |
|
|
|
|
⚫ |
*] |
|
|
|
|
|
|
{{Kava}} |
|
{{Kava}} |
|
|
{{Dopaminergics}} |
|
|
|
|
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
] |
|
|
] |
|
|
|
|
|
|
|
{{nervous-system-drug-stub}} |
|